Call Now: +1 858 800 3101 Email: info@innopep.com
| Overview | |
|---|---|
| Description | The epidermal growth factor receptor variant III (EGFRvIII) is a consistent tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms. As such it represents a truly tumor-specific target for antitumor immunotherapy. | 
| Sequence | {Leu}{Glu}{Glu}{Lys}{Lys}{Gly}{Asn}{Tyr}{Val}{Val}{Thr}{Asp}{His}{Cys} | 
| Sequence Shortening | LEEKKGNYVVTDHC | 
| Molecular Weight | 1634.82 | 
| Properties | |
| Purity | > 95% | 
| Gmp Flag | 0 | 
| Storage | Store at -20°C. | 
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.